Table 1B.
Specificity of IgM and IgG detection by Biolidics in patients without SARS-CoV-2.a
| Total, n | Positive, n | Specificity (%) | 95% CI | |
|---|---|---|---|---|
| IgM+ | 24 | 2 | 92% | 73–99% |
| IgG+ | 24 | 0 | 100% | 86–100% |
| IgG+ or IgM+ | 24 | 2 | 92% | 73–99% |
95% CI, 95% confidence interval.
Specificity of IgM and IgG detection by Biolidics in patients without SARS-CoV-2.a
| Total, n | Positive, n | Specificity (%) | 95% CI | |
|---|---|---|---|---|
| IgM+ | 24 | 2 | 92% | 73–99% |
| IgG+ | 24 | 0 | 100% | 86–100% |
| IgG+ or IgM+ | 24 | 2 | 92% | 73–99% |
95% CI, 95% confidence interval.